ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2025
First evidence of photoinactivation of rapidly growing mycobacteria by tetra-cationic porphyrins with peripheral cisplatin.
Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
This manuscript describes the evaluation of the photoinactivation of cationic meso-tetra(pyridyl)porphyrins combined with cisplatin as photosensitizers (PS) for the photodynamic inactivation of Rapidly Growing Mycobacteria (RGM) strains. Two porphyrin derivatives, 3-cis-PtTPyP and 4-cis-PtTPyP, were synthesized according to methodologies previously described in the literature. The Antimicrobial Photodynamic Therapy (aPDT) experiments were conducted on different RGM strains, including Mycobacteroides abscessus subsp. abscessus (ATCC 19977), Mycolicibacterium fortuitum (ATCC 6841), Mycobacteroides abscessus subsp. massiliense (ATCC 48898), and Mycolicibacterium smegmatis (ATCC 700084), using appropriate concentrations of PS under conditions of exposure to a white-light source for 90 min (irradiance of 50 mW cm
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.